Business
Neuronix’s neuroAD is already commercially available in Europe, Asia and Israel for slowing disease progression in mild to moderate Alzheimer cases.
Hi, what are you looking for?
Neuronix’s neuroAD is already commercially available in Europe, Asia and Israel for slowing disease progression in mild to moderate Alzheimer cases.
3Dot The 2016 Business Opportunities in Israel Lasers Electro-Optics conference was held at the Lev Academic Center in Jerusalem last week. A number of...
An annual contest selecting the most innovative startup in the field of cyber defense; The five competing finalists: Minerva, Intsights, Deep Instinct, Solebit Labs,...
TAU researcher's cutting-edge innovation pinpoints top candidates for assisted reproductive technology
Gadgets developed in Israel for your four-legged furry family members that are, literally, the cat's meow.
CartiHeal, developer of a novel joint-repair solution, raises $15m investment to advance clinical trials ahead of 2017 European launch.